Ashwin Karanam

Appearances

ASSESSMENT OF KAN-101 IN CED AND IMMUNE TOLERANCE (ACED-IT) STUDY, PH1B DATA WITH HIGHER DOSE LEVELS OF KAN-101, A NOVEL IMMUNE TOLERANCE THERAPY FOR CELIAC DISEASE
Date
May 19, 2024
Background: Celiac disease (CeD) is a chronic inflammatory disorder triggered and maintained by ingestion of gluten. The only treatment is a gluten-free diet as no pharmaceutical treatment is available…
Speakers
Jack Tseng
Stephanie Morgan
Dina Wassaf
Jyoti Ramakrishna
Ashwin Karanam
Mohamed Hassanein
William Treem
Tom Thornley
Presenter
Kristie Grebe